| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.957 | 12.004 | 11.982 | 12.001 | 12.702 | 12.909 | 15.168 | 15.968 | 15.631 | 15.629 |
| Total Income - EUR | 12.520 | 12.004 | 11.982 | 12.001 | 12.702 | 12.909 | 15.168 | 15.968 | 15.631 | 15.629 |
| Total Expenses - EUR | 6.468 | 5.397 | 5.237 | 5.086 | 9.423 | 6.546 | 5.443 | 6.140 | 13.586 | 15.070 |
| Gross Profit/Loss - EUR | 6.052 | 6.607 | 6.745 | 6.915 | 3.280 | 6.363 | 9.725 | 9.828 | 2.045 | 559 |
| Net Profit/Loss - EUR | 5.676 | 6.247 | 6.385 | 6.555 | 2.899 | 5.976 | 9.270 | 9.349 | 1.889 | 403 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Pemafarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 105.363 | 102.819 | 101.492 | 95.283 | 92.167 | 88.579 | 85.003 | 83.916 | 82.366 | 82.066 |
| Current Assets | 5.852 | 6.120 | 6.545 | 7.304 | 9.992 | 8.776 | 9.482 | 18.333 | 9.035 | 11.541 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.201 | 5.709 | 6.491 | 6.901 | 7.989 | 7.926 | 7.753 | 7.762 | 7.743 | 8.032 |
| Cash | 651 | 412 | 54 | 403 | 2.003 | 850 | 1.730 | 10.571 | 1.292 | 3.509 |
| Shareholders Funds | 65.213 | 70.795 | 75.983 | 78.670 | 80.045 | 84.504 | 91.900 | 101.535 | 89.933 | 89.833 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 46.001 | 38.144 | 32.054 | 23.983 | 22.114 | 12.852 | 2.585 | 714 | 1.468 | 3.774 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Pemafarm Srl